Revvity | PKI - Umsatzerlöse





Der Umsatz Veränderung Datum
Agilent USD 1.84B 37M 2026-03
Align Technology USD 1.06B 20M 2026-06
Bio Techne USD 321.2M 9.8M 2026-06
Bio-Rad Laboratories USD 651M 58.9M 2026-06
Bruker USD 838.5M 15.1M 2026-06
Celltrion KRW 1.24T 90B 2026-06
Charles River Laboratories USD 1000M 4.2M 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Danaher USD 6.3B 350M 2026-06
Dentsply International USD 898M 18M 2026-06
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Edwards Lifesciences USD 1.74B 90M 2026-06
Illumina USD 1.16B 70M 2026-06
Intuitive Surgical USD 2.89B 120M 2026-06
IQVIA Holdings USD 4.37B 220M 2026-06
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Laboratory Of America USD 3.73B 190M 2026-06
Medical Developments International AUD 21.57M 12.04M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Mettler Toledo International USD 1.03B 82.87M 2026-06
Myriad Genetics USD 190.7M 9.7M 2026-06
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pacific Biosciences Of California USD 44.64M 6.2M 2025-12
Pharma Mar EUR 50M 7.1M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Quest Diagnostics USD 3.04B 140M 2026-06
Quidel USD 630.9M 10.9M 2026-06
Repligen USD 204M 10M 2026-06
Revvity USD 729.68M 18.68M 2026-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Thermo Fisher Scientific USD 11.99B 980M 2026-06
Tilray USD 217.51M 74.75M 2025-12
Waters USD 1.64B 370M 2026-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03